Life Spine announced today that it received FDA clearance for its Prolift Wedge expandable spacer system.
The Prolift Wedge expandable interbody spacer system with Osseo-Loc surface technology is a lordotic expandable implant for use in micro-invasive transforaminal lumbar interbody fusion (TLIF) and posterior lumbar interbody fusion (PLIF) procedures, according to a news release.
Huntley, Ill.-based Life Spine’s device is designed to maintain coronal alignment while achieving sagittal correction through up to 15 degrees of controlled lordotic expansion. It includes multiple implant height and width options to optimally fit a patient’s disc anatomy, too.
Once a patient-specific correction has been made with the height and width, the wedge is auto-locked in position and can be packed with graft in situ through Life Spine’s Osteo-Line graft delivery device.
“The launch of Prolift Wedge furthers our commitment to offering patient matched expandable solutions,” Life Spine SVP of sales & marketing Mariusz Knap said in the release. “Prolift Wedge is another innovative expandable interbody added to our existing portfolio providing surgeons with multiple solutions for improving patient care.”